StockWatch
·
Pharmaceuticals
Auditor12 Aug 2026, 06:13 pm

Mangalam Drugs Appoints Secretarial Auditor for 5 Years

AI Summary

Mangalam Drugs & Organics Ltd announced the appointment of M/s L.N. Joshi & Co. as Secretarial Auditors for a term of five years, from FY 2026-27 to 2030-31. This appointment is subject to shareholder approval at the upcoming 53rd Annual General Meeting (AGM). The Board of Directors also approved the Un-Audited Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. Additionally, M/s SN. Nanda & Co. was appointed as Statutory Auditors for a similar five-year term, also pending shareholder approval.

Key Highlights

  • Secretarial Auditor appointed for a 5-year term.
  • Appointment subject to shareholder approval at the 53rd AGM.
  • Statutory Auditors also appointed for a 5-year term.
  • Unaudited financial results for Q1 FY27 approved.